ATLANTA, GEORGIA / ACCESS Newswire / October 28, 2025 / Florence Healthcare, the leading clinical trial platform connecting pharmaceutical sponsors and research sites worldwide, announced today that ...

Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a ...

Additionally, in the U.S., MONJUVI® (tafasitamab-cxix) is approved by the U.S. Food and Drug Administration in combination with lenalidomide and rituximab for the treatment of adult patients with ...

Generic versions of biologic drugs could hit the market without human trials and allow the market forces to bring down costs, ...

The Future of CNS Trial Designs Guided by AI-Powered Insights ...

Organon stock plunged after CEO's exit and audit probe. Discover if its low valuation, global portfolio, and earnings ...

Amryta’s Sodesta gene therapy gains accelerated approval for ALS The Food and Drug Administration has granted accelerated ...

First outcomes-based b2b payments platform proves what CFOs actually want: measurable financial results LAS VEGAS, NV / ACCESS Newswire / October 27, 2025 / Finexio, the leader in embedded b2b ...

Over the past few years, we have driven remarkable progress accelerating AI innovation together with our customers and partners. We are achieving efficiency and productivity at scale to shape ...

InstantGMP™, the innovators in manufacturing and quality management software for the pharmaceutical, supplement, and biotech industries, today announced the release of its new Laboratory Information ...

Incyte’s decision to scrap work on its BET inhibitor program has not surprised analysts, who pointed to safety concerns ...